The White House said the bill "falls far short" of the necessary funding, but Obama would sign it "because some action is better than none." » Read More
A new device that drains a portion of a person's stomach contents after every meal, has just won approval from the U.S. Food and Drug Administration.
An angry customer filed a class action lawsuit against Theranos in the district of Northern California, The Verge reports.
These professors point out some "glaring errors" in the attack on Bernie Sanders' single-payer health plan.
It's been a brutal year for Valeant, and one trader is betting the bad news is about to get much worse for the drug company's stock.
Is the biotech industry having a good year or a slow one? Expert analysts weigh in on CNBC's "Power Lunch."
Zika shouldn't have caught us by surprise, writes Dr. Claire Pomeroy. Here's what needs to be done to prevent the next killer virus.
"Maude" creator Norman Lear can't believe a woman’s right to choose is still under fire. It has a huge impact on their lives and careers.
A co-author of the study that found variability in Theranos medical tests said they plan to make their protocols public.
The cosmetic medical procedure is gaining favor among both men and women.
Benzhong Tang from Hong Kong University of Science and Technology, explains how he developed an AIE fluorescent material dyes cancer cells, making them easier to track.
Ulrich Spiesshofer, CEO of ABB, says his company needs to readjust its efforts, especially in China where sluggish demand hit profits.
Researchers are testing way to detect the presence of the disease in almost all types of cancer mutations.
The recent criticism surrounding $9 billion diagnostics firm Theranos has been unfair, Theranos board member Richard Kovacevich tells CNBC.
CVS, Chevron, and J&J are among Michael Farr's top 10 stock picks for 2016. Here's why those and seven others made the list.
Two years after the outbreak began, Guinea has been declared free of the Ebola virus, the World Health Organization said Tuesday.
Eswar Prasad, senior professor of trade policy at Cornell University, says while China's manufacturing sector is in sharp decline, there is strength in China's services and consumption sectors.
Rising demand for IVF in China will strain already-crowded state-run hospitals but create opportunities for overseas health centers.
CEO and MD Christina Holgate tells CNBC why the Supplement brand Blackmores decided to open its first retail store.
Junior doctors in the U.K. are set to strike next month, which could see thousands of operations and appointments delayed or canceled.
After Caterpillar posts an earnings miss, CEO Doug Oberhelman said "Our day will come, but it's not right now."
Get the best of CNBC in your inbox